Efficacy and Safety of Opicapone in Clinical Practice in Parkinson's Disease Patients With Wearing-off Motor Fluctuations
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2018
At a glance
- Drugs Opicapone (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms OPTIPARK
- Sponsors Bial
- 23 Mar 2018 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.
- 23 Mar 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.
- 23 Mar 2018 Status changed from recruiting to active, no longer recruiting.